Published on Massachusetts Alzheimer's Disease Research Center (http://madrc.mgh.harvard.edu)

Home > The Rationale and Design of the Antihypertensives and Vascular, Endothelial, and Cognitive Function (AVEC) Trial in Elderly Hypertensives with Early Cognitive Impairment: Role of the Main Angiotensin System Disinhibition

The Rationale and Design of the Antihypertensives and Vascular, Endothelial, and Cognitive Function (AVEC) Trial in Elderly Hypertensives with Early Cognitive Impairment: Role of the Main Angiotensin System Disinhibition

Publication Date: 
2009

Hajjar I, Hart M, Milberg W, Novak V and Lipsitz L (2009). The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment:  Role of the renin angiotensin system inhibition. BMC Geriatrics; 9: 48. November 18. Epub Ahead of Print. PMCID:  2784465.

Massachusetts General Hospital, Warren Building Suite 844, 55 Fruit Street, Boston, Massachusetts 02114, USA
Telephone: 617-726-3987 | Facsimile: 617-726-7718
© January 1, 2010 All Rights Reserved